Spots Global Cancer Trial Database for recurrent childhood rhabdomyosarcoma
Every month we try and update this database with for recurrent childhood rhabdomyosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma | NCT01222715 | Adult Rhabdomyo... Childhood Alveo... Childhood Pleom... Childhood Rhabd... Previously Trea... Recurrent Adult... Recurrent Child... | Bevacizumab Cyclophosphamid... Laboratory Biom... Temsirolimus Vinorelbine Tar... | - 29 Years | National Cancer Institute (NCI) | |
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma | NCT01626170 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma | NCT06040229 | Alveolar Childh... Embryonal Child... Recurrent Child... | 1 Year - 18 Years | Shandong First Medical University | ||
Ex Vivo Drug Sensitivity Testing and Mutation Profiling | NCT03860376 | Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chil... Refractory Chil... Refractory Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... | 1 Day - 21 Years | Florida International University | ||
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma | NCT01626170 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma | NCT00055939 | Sarcoma | exatecan mesyla... | - | Daiichi Sankyo | |
Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma | NCT01342783 | Sarcoma | DNA analysis RNA analysis mutation analys... nucleic acid se... laboratory biom... | - 18 Years | Children's Oncology Group | |
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma | NCT00919269 | Adult Rhabdomyo... Childhood Desmo... Chordoma Desmoid-Type Fi... Metastatic Chil... Non-Metastatic ... Previously Trea... Recurrent Adult... Recurrent Child... Recurrent Child... Rhabdomyosarcom... Stage I Adult S... Stage II Adult ... Stage III Adult... Stage IV Adult ... Untreated Child... | Cytology Specim... Laboratory Biom... | - 50 Years | Children's Oncology Group | |
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma | NCT01609803 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - 21 Years | Children's Oncology Group | |
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma | NCT06040229 | Alveolar Childh... Embryonal Child... Recurrent Child... | 1 Year - 18 Years | Shandong First Medical University | ||
Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma | NCT06040229 | Alveolar Childh... Embryonal Child... Recurrent Child... | 1 Year - 18 Years | Shandong First Medical University | ||
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors | NCT01158300 | Brain and Centr... | VEGF inhibitor ... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | NCT00025363 | Alveolar Childh... Embryonal Child... Embryonal-botry... Previously Trea... Recurrent Child... | vincristine sul... irinotecan hydr... cyclophosphamid... doxorubicin hyd... ifosfamide etoposide tirapazamine filgrastim sargramostim pharmacological... pharmacogenomic... laboratory biom... | - 20 Years | National Cancer Institute (NCI) | |
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma | NCT01426945 | Sarcoma | protein express... immunohistochem... laboratory biom... | - | Children's Oncology Group | |
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma | NCT01609803 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - 21 Years | Children's Oncology Group | |
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors | NCT00070109 | Previously Trea... Recurrent Child... Recurrent Child... Recurrent Ewing... Peripheral Prim... | trabectedin pharmacological... | 12 Months - 50 Years | Children's Oncology Group | |
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | NCT00025363 | Alveolar Childh... Embryonal Child... Embryonal-botry... Previously Trea... Recurrent Child... | vincristine sul... irinotecan hydr... cyclophosphamid... doxorubicin hyd... ifosfamide etoposide tirapazamine filgrastim sargramostim pharmacological... pharmacogenomic... laboratory biom... | - 20 Years | National Cancer Institute (NCI) | |
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) | NCT03155620 | Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Histiocytic Sar... Juvenile Xantho... Langerhans Cell... Malignant Gliom... Recurrent Child... Recurrent Epend... Recurrent Ewing... Recurrent Gliom... Recurrent Hepat... Recurrent Lange... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Prima... Recurrent Rhabd... Recurrent Soft ... Refractory Ewin... Refractory Glio... Refractory Hepa... Refractory Lang... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Prim... Refractory Rhab... Refractory Rhab... Rhabdoid Tumor Stage III Osteo... Stage III Soft ... Stage IV Osteos... Stage IV Soft T... Stage IVA Osteo... Stage IVB Osteo... Wilms Tumor | Biopsy Biospecimen Col... Bone Marrow Asp... Bone Scan Computed Tomogr... Ensartinib Erdafitinib Laboratory Biom... Larotrectinib S... Magnetic Resona... Mutation Carrie... Olaparib Palbociclib Pharmacological... Positron Emissi... Radionuclide Im... Samotolisib Selpercatinib Selumetinib Sul... Tazemetostat Tipifarnib Ulixertinib Vemurafenib X-Ray Imaging | 12 Months - 21 Years | National Cancer Institute (NCI) |